+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Zerbaxa 2018 U.S. Promotional Audit Report

  • ID: 4615975
  • Report
  • Region: United States
  • 28 pages
  • MD Details
1 of 3

FEATURED COMPANIES

The 5 Key Questions Addressed by this Report:
  • How many physicians were reached by Zerbaxa through reportable promotional activity in 2018 and how does this compare to its peer set in the Intra-Abdominal Infection, Severe Infection, and Urinary Tract Infection markets?
  • What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend for each type of activity?
  • How does Merck's depth of coverage vary within key specialties (e.g., Internal Medicine, Infectious Disease, Pulmonology, Critical Care Medicine, General Surgery, and Family Medicine) and how does this compare to its peers and the overall set of rep-accessible physicians?
  • How often are physicians receiving paid meals for Zerbaxa throughout the year (e.g., monthly, quarterly, annually)?
  • Who were the most frequent meal recipients and top paid speakers for Zerbaxa in 2018?
Data Sources and Methodology:
  • Author leverages company-reported financial transaction data disclosed through CMS Open Payments. This data set captures all transfers of value (e.g., speaking fees, consulting fees, travel, education, and meals) made on behalf of a drug or device manufacturer to a physician. Currently, over 5 years of longitudinal data is available - covering payments to more than 1,000,000 U.S. healthcare professionals.
  • Over 10,000 paid interactions across 4,700 physicians made on behalf of Zerbaxa were carefully examined to support our analysis. In addition, interaction data from 9 peer products (i.e. Avycaz, Baxdela, Dalvance, Minocin, Orbactiv, Sivextro, Teflaro, Vabomere, and Vibativ) was leveraged to provide benchmarking and market insights.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

Overview:
  • Introduction
  • Sunshine Act and Open Payments Data
  • Transfer of Value
  • Author's Platform
Zerbaxa - Peer Set:
  • Zerbaxa Peer Set Selection
Zerbaxa - Promotional Benchmarking:
  • Chart 1 Total Number of Physicians Reached by Specialty Type
  • Chart 2 Distribution of Physicians Reached by Specialty Type
  • Chart 3 Total Number of Payments by Type
  • Chart 4 Distribution of Payments by Type
  • Chart 5 Total Number of Payments / Week
  • Chart 6 Payment Value by Type
Zerbaxa - Physician Coverage by Geography:
  • Chart 7 Internal Medicine
  • Chart 8 Infectious Disease
  • Chart 9 Pulmonology
  • Chart 10 Critical Care Medicine
  • Chart 11 General Surgery
  • Chart 12 Family Medicine
Zerbaxa - Meal Frequency:
  • Chart 13 Internal Medicine
  • Chart 14 Infectious Disease
  • Chart 15 Pulmonology
  • Chart 16 Critical Care Medicine
  • Chart 17 General Surgery
  • Chart 18 Family Medicine
Zerbaxa - Most Engaged Physicians:
  • Table 1: Top Physicians (By Total Number of Meals) in 2018
  • Table 2: Top Speakers (By Total Number of Speaking Events) in 2018
About:
  • Background
  • Service Lines
  • Contact
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Merck
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4615975
Adroll
adroll